Literature DB >> 18037599

Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories.

J Ezzelle1, I R Rodriguez-Chavez, J M Darden, M Stirewalt, N Kunwar, R Hitchcock, T Walter, M P D'Souza.   

Abstract

A set of Good Clinical Laboratory Practice (GCLP) standards that embraces both the research and clinical aspects of GLP were developed utilizing a variety of collected regulatory and guidance material. We describe eleven core elements that constitute the GCLP standards with the objective of filling a gap for laboratory guidance, based on IND sponsor requirements, for conducting laboratory testing using specimens from human clinical trials. These GCLP standards provide guidance on implementing GLP requirements that are critical for laboratory operations, such as performance of protocol-mandated safety assays, peripheral blood mononuclear cell processing and immunological or endpoint assays from biological interventions on IND-registered clinical trials. The expectation is that compliance with the GCLP standards, monitored annually by external audits, will allow research and development laboratories to maintain data integrity and to provide immunogenicity, safety, and product efficacy data that is repeatable, reliable, auditable and that can be easily reconstructed in a research setting.

Entities:  

Mesh:

Year:  2007        PMID: 18037599      PMCID: PMC2213906          DOI: 10.1016/j.jpba.2007.10.010

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay.

Authors:  Sheri Dubey; James Clair; Tong-Ming Fu; Liming Guan; Romnie Long; Robin Mogg; Kiersten Anderson; Kelly B Collins; Christine Gaunt; V Rose Fernandez; Lan Zhu; Lisa Kierstead; Scott Thaler; Swati B Gupta; Walter Straus; Devan Mehrotra; Timothy W Tobery; Danilo R Casimiro; John W Shiver
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

2.  Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination.

Authors:  Helen Horton; Evan P Thomas; Jason A Stucky; Ian Frank; Zoe Moodie; Yunda Huang; Ya-Lin Chiu; M Juliana McElrath; Stephen C De Rosa
Journal:  J Immunol Methods       Date:  2007-04-03       Impact factor: 2.303

3.  Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.

Authors:  Josephine H Cox; Guido Ferrari; Spyros A Kalams; Wlodek Lopaczynski; Neal Oden; M Patricia D'souza
Journal:  AIDS Res Hum Retroviruses       Date:  2005-01       Impact factor: 2.205

4.  Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.

Authors:  Marta Bull; Deborah Lee; Jason Stucky; Ya-Lin Chiu; Abbe Rubin; Helen Horton; M Juliana McElrath
Journal:  J Immunol Methods       Date:  2007-02-28       Impact factor: 2.303

5.  Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity.

Authors:  Nina D Russell; Michael G Hudgens; Richard Ha; Colin Havenar-Daughton; M Juliana McElrath
Journal:  J Infect Dis       Date:  2003-01-06       Impact factor: 5.226

6.  Standardization of cytokine flow cytometry assays.

Authors:  Holden T Maecker; Aline Rinfret; Patricia D'Souza; Janice Darden; Eva Roig; Claire Landry; Peter Hayes; Josephine Birungi; Omu Anzala; Miguel Garcia; Alexandre Harari; Ian Frank; Ruth Baydo; Megan Baker; Jennifer Holbrook; Janet Ottinger; Laurie Lamoreaux; C Lorrie Epling; Elizabeth Sinclair; Maria A Suni; Kara Punt; Sandra Calarota; Sophia El-Bahi; Gailet Alter; Hazel Maila; Ellen Kuta; Josephine Cox; Clive Gray; Marcus Altfeld; Nolwenn Nougarede; Jean Boyer; Lynda Tussey; Timothy Tobery; Barry Bredt; Mario Roederer; Richard Koup; Vernon C Maino; Kent Weinhold; Giuseppe Pantaleo; Jill Gilmour; Helen Horton; Rafick P Sekaly
Journal:  BMC Immunol       Date:  2005-06-24       Impact factor: 3.615

  6 in total
  44 in total

Review 1.  Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents.

Authors:  Denise M O'Hara; Valerie Theobald; Adrienne Clements Egan; Joel Usansky; Murli Krishna; Julie TerWee; Mauricio Maia; Frank P Spriggs; John Kenney; Afshin Safavi; Jeannine Keefe
Journal:  AAPS J       Date:  2012-03-14       Impact factor: 4.009

2.  Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing.

Authors:  Maria C Jaimes; Holden T Maecker; Ming Yan; Vernon C Maino; Mary Beth Hanley; Angela Greer; Janice M Darden; M Patricia D'Souza
Journal:  J Immunol Methods       Date:  2010-08-19       Impact factor: 2.303

Review 3.  Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.

Authors:  Darshana Jani; John Allinson; Flora Berisha; Kyra J Cowan; Viswanath Devanarayan; Carol Gleason; Andreas Jeromin; Steve Keller; Masood U Khan; Bill Nowatzke; Paul Rhyne; Laurie Stephen
Journal:  AAPS J       Date:  2015-09-16       Impact factor: 4.009

4.  The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.

Authors:  Ana M Sanchez; Wes Rountree; Mark Berrong; Ambrosia Garcia; Alexandra Schuetz; Josephine Cox; Nicole Frahm; Mark Manak; Marcella Sarzotti-Kelsoe; M Patricia D'Souza; Thomas Denny; Guido Ferrari
Journal:  J Immunol Methods       Date:  2014-03-28       Impact factor: 2.303

5.  Ligand binding assay critical reagents and their stability: recommendations and best practices from the Global Bioanalysis Consortium Harmonization Team.

Authors:  Lindsay E King; Esme Farley; Mami Imazato; Jeannine Keefe; Masood Khan; Mark Ma; K Susanne Pihl; Priya Sriraman
Journal:  AAPS J       Date:  2014-04-01       Impact factor: 4.009

6.  Optimization of a highly standardized carboxyfluorescein succinimidyl ester flow cytometry panel and gating strategy design using discriminative information measure evaluation.

Authors:  Cliburn Chan; Lin Lin; Jacob Frelinger; Valérie Hérbert; Dominic Gagnon; Claire Landry; Rafick-Pierre Sékaly; Jennifer Enzor; Janet Staats; Kent J Weinhold; Maria Jaimes; Mike West
Journal:  Cytometry A       Date:  2010-12       Impact factor: 4.355

7.  Laboratory challenges conducting international clinical research in resource-limited settings.

Authors:  Joseph E Fitzgibbon; Carole L Wallis
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

8.  Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN).

Authors:  Heiman F L Wertheim; Pilaipan Puthavathana; Ngoc My Nghiem; H Rogier van Doorn; Trung Vu Nguyen; Hung Viet Pham; Decy Subekti; Syahrial Harun; Suhud Malik; Janet Robinson; Motiur Rahman; Walter Taylor; Niklas Lindegardh; Steve Wignall; Jeremy J Farrar; Menno D de Jong
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

9.  Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: lessons learned from a microbicide phase III clinical trial.

Authors:  Tania Crucitti; Katrien Fransen; Rashika Maharaj; Tom Tenywa; Marguerite Massinga Loembé; Kailapuri Gangatharan Murugavel; Kevin Mendonca; Said Abdellati; Greet Beelaert; Lut Van Damme
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

10.  Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

Authors:  Marcella Sarzotti-Kelsoe; Robert T Bailer; Ellen Turk; Chen-li Lin; Miroslawa Bilska; Kelli M Greene; Hongmei Gao; Christopher A Todd; Daniel A Ozaki; Michael S Seaman; John R Mascola; David C Montefiori
Journal:  J Immunol Methods       Date:  2013-12-01       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.